Role Of Interleukin-6 (-174 G/C) Gene Promoter Polymorphism And Il-6 Levels In Risk Prediction Of Coronary Artery Disease In Young Pakistani Subjects
- Publisher:
- nternational Journal of Advances in Science, Engineering and Technology(IJASEAT)-IJASEAT
- Publication Type:
- Journal Article
- Citation:
- International Journal of Advances in Science, Engineering and Technology (IJASEAT), 2015, 3, (4, Spl. Iss-3 ( Oct, 2015 )), pp. 83-86
- Issue Date:
- 2015-12-04
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
6-205-144921209283-86.pdf | Published version | 227.5 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
IL-6 is a pleiotropic cytokine which actively participates in the immune-inflammatory process
underlying the pathogenesis of CAD.The most widely studied of these is the -174 G/C variant in the IL-6 gene
promoter region. there is still paucity of studies reporting the effect of the IL-6 gene promoter SNP -174 G/C
(Rs1800795) on the serum IL-6 levels and the risk prediction of CAD in Premature coronary artery disease
patients of Pakistan. Hence, we sought to assess the role of the IL-6 gene promoter SNP -174 G/C(Rs1800795)
and IL-6 serum levels in the diagnosis and risk prediction of PCAD patients.
Please use this identifier to cite or link to this item: